RAC 3.31% $1.61 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-163

  1. 1,526 Posts.
    lightbulb Created with Sketch. 379
    It really makes it easy to visualise doesn’t it, it sadly I can’t take credit for making it.
    Basically RAC all stage 2 in the preclinical & clinical early stages.

    Just to get Bisantrene to this stage is indeed fortunate especially after being shelved/abandoned at one stage before RAC picked it back up. Thankfully due to previous trials & safety data in humans RAC have a massive headstart & have saved 100s of millions of dollars.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.